↓ Skip to main content

Toripalimab in Combination With Induction Chemotherapy and Subsequent Chemoradiation as First-Line Treatment in Patients With Advanced/Metastatic Esophageal Carcinoma: Protocol for a Single-Arm…

Overview of attention for article published in Frontiers in oncology, April 2022
Altmetric Badge

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Toripalimab in Combination With Induction Chemotherapy and Subsequent Chemoradiation as First-Line Treatment in Patients With Advanced/Metastatic Esophageal Carcinoma: Protocol for a Single-Arm, Prospective, Open-Label, Phase II Clinical Trial (TR-EAT)
Published in
Frontiers in oncology, April 2022
DOI 10.3389/fonc.2022.878851
Pubmed ID
Authors

Lei Wu, Yi Wang, Baisen Li, Gang Wan, Long Liang, Tao Li, Jinyi Lang, Qifeng Wang

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 3 20%
Unspecified 1 7%
Student > Bachelor 1 7%
Student > Doctoral Student 1 7%
Student > Ph. D. Student 1 7%
Other 1 7%
Unknown 7 47%
Readers by discipline Count As %
Medicine and Dentistry 3 20%
Nursing and Health Professions 2 13%
Sports and Recreations 1 7%
Unspecified 1 7%
Unknown 8 53%